Title: Full Text of HR0233
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HR0233 ILGA.GOV HR0233 - 104th General Assembly HR0233LRB104 12956 MST 24523 r1HOUSE RESOLUTION 2    WHEREAS, Topical steroid withdrawal syndrome (TSWS), also 3known as topical steroid addiction or red skin syndrome, is a 4severe, debilitating condition that can arise from intentional 5or unintentional exposure to topical steroids; and 6    WHEREAS, Topical steroids are widely prescribed and 7purchased over the counter to treat acute as well as chronic 8skin conditions, such as eczema, psoriasis, vitiligo, and 9alopecia areata; and 10    WHEREAS, TSWS is characterized by skin flushing, 11inflammation, diffuse spreading rashes, profuse skin flaking, 12burning, and itching worse than the original condition that 13typically appear after use of topical steroid treatments, 14between treatments, or after discontinuing topical steroids; 15and 16    WHEREAS, It can take several months to several years for 17symptoms to subside, leaving some TSWS sufferers bedridden and 18housebound and unable to work, to care for children, or to go 19to school; and 20    WHEREAS, A prolonged withdrawal and recovery period can 21take a significant toll on patients' mental health as well as   HR0233- 2 -LRB104 12956 MST 24523 r1their physical health; 81% of adults and 56% of children 2experiencing TSWS report feeling anxious and/or depressed, and 347% of adults and 11% of children experiencing TSWS report 4suicidal ideation; and 5    WHEREAS, The prevalence of topical steroid addiction is 6unknown due to a scarcity of published research; and 7    WHEREAS, The scarcity of research on TSWS impedes efforts 8to define diagnostic criteria for TSWS, understand its causes, 9mechanics, and effects, develop appropriate treatment 10protocols, and educate providers and patients about TSWS and 11steroid stewardship; and 12    WHEREAS, Lack of awareness of and education about TSWS 13among patients and providers can lead to friction between 14them, causing patients to question their providers' medical 15oversight and causing providers to suspect their patients of 16medication non-compliance and, occasionally, parental neglect; 17and 18    WHEREAS, All parties would benefit greatly from awareness 19and prevention education on the signs of topical steroid 20dependence and the risks of TSWS; therefore, be it 21    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE   HR0233- 3 -LRB104 12956 MST 24523 r1HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that 2we declare February 3, 2026 as Topical Steroid Withdrawal 3Syndrome Awareness Day in the State of Illinois.


================================================================================

Raw Text:
Full Text of HR0233 ILGA.GOV HR0233 - 104th General Assembly HR0233LRB104 12956 MST 24523 r1HOUSE RESOLUTION 2    WHEREAS, Topical steroid withdrawal syndrome (TSWS), also 3known as topical steroid addiction or red skin syndrome, is a 4severe, debilitating condition that can arise from intentional 5or unintentional exposure to topical steroids; and 6    WHEREAS, Topical steroids are widely prescribed and 7purchased over the counter to treat acute as well as chronic 8skin conditions, such as eczema, psoriasis, vitiligo, and 9alopecia areata; and 10    WHEREAS, TSWS is characterized by skin flushing, 11inflammation, diffuse spreading rashes, profuse skin flaking, 12burning, and itching worse than the original condition that 13typically appear after use of topical steroid treatments, 14between treatments, or after discontinuing topical steroids; 15and 16    WHEREAS, It can take several months to several years for 17symptoms to subside, leaving some TSWS sufferers bedridden and 18housebound and unable to work, to care for children, or to go 19to school; and 20    WHEREAS, A prolonged withdrawal and recovery period can 21take a significant toll on patients' mental health as well as   HR0233- 2 -LRB104 12956 MST 24523 r1their physical health; 81% of adults and 56% of children 2experiencing TSWS report feeling anxious and/or depressed, and 347% of adults and 11% of children experiencing TSWS report 4suicidal ideation; and 5    WHEREAS, The prevalence of topical steroid addiction is 6unknown due to a scarcity of published research; and 7    WHEREAS, The scarcity of research on TSWS impedes efforts 8to define diagnostic criteria for TSWS, understand its causes, 9mechanics, and effects, develop appropriate treatment 10protocols, and educate providers and patients about TSWS and 11steroid stewardship; and 12    WHEREAS, Lack of awareness of and education about TSWS 13among patients and providers can lead to friction between 14them, causing patients to question their providers' medical 15oversight and causing providers to suspect their patients of 16medication non-compliance and, occasionally, parental neglect; 17and 18    WHEREAS, All parties would benefit greatly from awareness 19and prevention education on the signs of topical steroid 20dependence and the risks of TSWS; therefore, be it 21    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE   HR0233- 3 -LRB104 12956 MST 24523 r1HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that 2we declare February 3, 2026 as Topical Steroid Withdrawal 3Syndrome Awareness Day in the State of Illinois.